ArticleFrontiers in oncology2020
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 31% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis.Frontiers in oncology · 2021Pooled it
- Optimizing the delivery of radiotherapy with artificial intelligence.Nature reviews. Clinical oncology · 2026Review
- Prediction models of adverse outcomes following surgery and radiotherapy for breast cancer: a systematic review.ESMO real world data and digital oncology · 2026Review
- Patterns of Postmastectomy Radiotherapy in Immediate Breast Reconstruction-Results From the iBRA-2 Cohort Study.International journal of breast cancer · 2026Article
- Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapy.Breast (Edinburgh, Scotland) · 2025Article
- A dosiomics model for prediction of radiation-induced acute skin toxicity in breast cancer patients: machine learning-based study for a closed bore linac.European journal of medical research · 2024Article
- Article
- Patients' experiences of engaging with electronic Patient Reported Outcome Measures (PROMs) after the completion of radiation therapy for breast cancer: a pilot service evaluation.Journal of medical radiation sciences · 2023Article
- Longitudinal cosmetic outcome after planned IORT boost with low kV X-rays-monocentric results from the TARGIT BQR registry.Translational cancer research · 2023Article
- Predicting acute radiation dermatitis in breast cancer: a prospective cohort study.BMC cancer · 2023Article
- The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review.Cancers · 2022Review
- Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort.Advances in radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 17 institutions in 8 countries.
Tim RattayCancer Research Centre, University of Leicester, Leicester, United Kingdom.
Petra SeiboldDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Miguel E Aguado-BarreraFundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.
Manuel AltabasRadiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
David AzriaFédération Universitaire d'Oncologie Radiothérapie d'Occitanie Méditérranée, Département d'Oncologie Radiothérapie, ICM Montpellier, INSERM U1194 IRCM, University of Montpellier, Montpellier, France.
Gillian C BarnettDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom.
Renée BultijnckDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ananya ChoudhuryTranslational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Charlotte E ColesDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom.
Alison M DunningCentre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom.
Rebecca M ElliottTranslational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Marie-Pierre Farcy JacquetFédération Universitaire d'Oncologie Radiothérapie d'Occitanie Méditérranée, Département d'Oncologie Radiothérapie, CHU Carémeau, Nîmes, France.
Sara Gutiérrez-EnríquezHereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, Barcelona, Spain.
Kerstie JohnsonCancer Research Centre, University of Leicester, Leicester, United Kingdom.
Anusha MüllerDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Giselle PostDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Tiziana RancatiProstate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Victoria ReyesRadiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Barry S RosensteinDepartment of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Dirk De RuysscherMAASTRO Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Maria C de SantisDepartment of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Elena SperkDepartment of Radiation Oncology, Universitätsklinikum Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Hilary StobartIndependent Cancer Patients' Voice, London, United Kingdom.
R Paul SymondsCancer Research Centre, University of Leicester, Leicester, United Kingdom.
Begoña Taboada-ValladaresInstituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Ana VegaFundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.
Liv VeldemanDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Adam J WebbDepartment of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
Catharine M WestTranslational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Riccardo ValdagniHereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, Barcelona, Spain.
Christopher J TalbotDepartment of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
REQUITE consortium
University of Leicester · GBVall d'Hebron Hospital Universitari · ESGhent University · BEFondazione IRCCS Istituto Nazionale dei Tumori · ITHeidelberg University · DEInstituto de Investigación Sanitaria de Santiago · ESThe Christie NHS Foundation Trust · GBUniversity of Cambridge · GBComplexo Hospitalario Universitario A Coruña · ESGerman Cancer Research Center · DEIcahn School of Medicine at Mount Sinai · USInserm · FRMaastricht University · NLManchester Academic Health Science Centre · GBMRC Epidemiology Unit · GBThe Patients Association · GBUniversity Hospital Heidelberg · DE
Funding
Department of Health DRF-2014-07-079Department of Health NIHR300024
Abstract
PubMed holds no abstract for this paper.
Indexed as
breast cancerearly toxicityprediction modelradiotherapyvalidation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.